‹‹‹ Click on the buttons to see the contents!

Educational Session - Renin-angiotensin system blockade as a basis for combination therapy
Supported by an unrestricted educational grant from AstraZeneca

Chairpersons: S.E. Kjeldsen (Oslo, Norway) and P.M. Nilsson (Malmo, Sweden)


 
Burden of hypertension and current levels of treatment and blood pressure control
G. Mancia (Milan, Italy)

[WEBCAST]  
 
 
Strategies for fixed combinations, what do guidelines say?
S.E. Kjeldsen (Oslo, Norway)

[WEBCAST]  
 
 
Should RAS blockade be an integral part in most combinations?
P. Trenkwalder (Starnberg, Germany)

[WEBCAST]  
 

 
Dual blockade in cardiovascular disease - when is this successful?
P.A. Meredith (Glasgow, UK)

[WEBCAST]  

<< back
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of ESHonline, and do not represent a publication of the European Society of Hypertension. These materials and the related activity are not sanctioned by the European Society of Hypertension and do not constitute an official part of that conference. These materials may discuss uses and dosages for therapeutic products that have not been approved by the nationals and internationals Laws. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © ESHonline.org.